Effect of OC000459 on Eosinophilic Airway Inflammation in Severe Asthma
Status:
Completed
Trial end date:
2018-08-02
Target enrollment:
Participant gender:
Summary
The aim is to study the effect of OC000459 on eosinophilic airway inflammation and asthma
control in subjects with severe, refractory eosinophilic asthma.